Dyno Therapeutics is an AI and biotechnology company building high-performance gene delivery technologies to unlock the potential of next-generation genetic medicine. Using its CapsidMap platform, which combines machine learning with high-throughput in vivo measurement, Dyno designs novel adeno-associated virus (AAV) capsids with improved tissue…

GenVec was a clinical-stage biopharmaceutical company founded in 1992 and headquartered in Gaithersburg, Maryland, that pioneered adenovector (AdenoVerse) gene-delivery technology to develop gene-based therapeutics and vaccines, including programs for hearing loss and balance disorders.